Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (51-60 of 662) with videos related to

Pageof 67
Sort By:
Blood|November 17, 2017
Anemia at older age: etiologies, clinical implications, and managementReinhard Stauder, Peter Valent, Igor Theurl
The Journal of Allergy and Clinical Immunology|April 29, 2022
Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?Cem Akin, Michel Arock, Peter Valent
Mediators of Inflammation|November 7, 2015
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsGregor Hoermann, Georg Greiner, Peter Valent
Current Allergy and Asthma Reports|February 3, 2024
Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?Peter Valent, Cem Akin, Michel Arock
The New England Journal of Medicine|November 5, 2015
Mast Cells, Mastocytosis, and Related DisordersTheoharis C Theoharides, Peter Valent, Cem Akin
Leukemia & Lymphoma|January 26, 2011
Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasmsPeter Valent, Karl Sotlar, Hans-Peter Horny
The Journal of Allergy and Clinical Immunology|November 2, 2010
Mast cell activation syndrome: Proposed diagnostic criteriaCem Akin, Peter Valent, Dean D Metcalfe
Blood|September 22, 2010
How I treat patients with advanced systemic mastocytosisPeter Valent, Wolfgang R Sperr, Cem Akin
Immunology and Allergy Clinics of North America|April 22, 2014
Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cellsHans-Peter Horny, Karl Sotlar, Peter Valent
Blood|December 30, 2016
Mastocytosis: 2016 updated WHO classification and novel emerging treatment conceptsPeter Valent, Cem Akin, Dean D Metcalfe
Pageof 67

Showing results (51-60 of 662) with videos related to

Sort By:
Pageof 67
Blood|November 17, 2017
Anemia at older age: etiologies, clinical implications, and managementReinhard Stauder, Peter Valent, Igor Theurl
The Journal of Allergy and Clinical Immunology|April 29, 2022
Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?Cem Akin, Michel Arock, Peter Valent
Mediators of Inflammation|November 7, 2015
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsGregor Hoermann, Georg Greiner, Peter Valent
Current Allergy and Asthma Reports|February 3, 2024
Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?Peter Valent, Cem Akin, Michel Arock
The New England Journal of Medicine|November 5, 2015
Mast Cells, Mastocytosis, and Related DisordersTheoharis C Theoharides, Peter Valent, Cem Akin
Leukemia & Lymphoma|January 26, 2011
Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasmsPeter Valent, Karl Sotlar, Hans-Peter Horny
The Journal of Allergy and Clinical Immunology|November 2, 2010
Mast cell activation syndrome: Proposed diagnostic criteriaCem Akin, Peter Valent, Dean D Metcalfe
Blood|September 22, 2010
How I treat patients with advanced systemic mastocytosisPeter Valent, Wolfgang R Sperr, Cem Akin
Immunology and Allergy Clinics of North America|April 22, 2014
Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cellsHans-Peter Horny, Karl Sotlar, Peter Valent
Blood|December 30, 2016
Mastocytosis: 2016 updated WHO classification and novel emerging treatment conceptsPeter Valent, Cem Akin, Dean D Metcalfe
Pageof 67